Meeting
2012 ASCO Annual Meeting
BRAF, PIK3CA, and PTEN status and benefit from cetuximab (CET) in the treatment of advanced colorectal cancer (CRC): Results from NCIC CTG/AGITG CO.17.
Authors
Derek J. Jonker
The Ottawa Hospital Research Institute, Ottawa, ON, Canada
Derek J. Jonker , Christos Stelios Karapetis , Christopher J. O'Callaghan , Celia Marginean , John Raymond Zalcberg , John Simes , Malcolm J. Moore , Niall Christopher Tebbutt , Timothy Jay Price , Manijeh Daneshmand , Jennifer Hanson , Jeremy David Shapiro , Nick Pavlakis , Peter Gibbs , Guy A. Van Hazel , Ursula Joan Yu Min Lee , Rashida Haq , Shakeel Virk , Dongsheng Tu , Ian Lorimer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 3515)
DOI
10.1200/jco.2012.30.15_suppl.3515
Abstract #
3515
Poster Bd #
7
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Comprehensive genomic profiling of clinically advanced colorectal carcinoma to reveal frequent opportunities for targeted therapies.
First Author: Jeffrey S. Ross
Poster
2015 Gastrointestinal Cancers Symposium
Prognostic value of RAS, BRAF, and PIK3CA mutations in early-stage colorectal cancer.
First Author: Jennifer Elizabeth Byer
Poster
2015 Gastrointestinal Cancers Symposium
The nationwide genomic screening project for gastrointestinal cancer in Japan (GI-SCREEN): Simultaneous identification of KRAS, NRAS, BRAF, and PIK3CA mutation in advanced colorectal cancer (aCRC) (GI-SCREEN 2013-01).
First Author: Kohei Shitara
Poster
2015 Gastrointestinal Cancers Symposium
Clinical and molecular characterization of refractory BRAF mutant metastatic colorectal carcinoma (mCRC): Vall d’Hebron Institute of Oncology phase I program cohort.
First Author: Enrique Sanz-Garcia